Published in
Elsevier, Gynecologic Oncology, (177), p. 60-71, 2023
DOI: 10.1016/j.ygyno.2023.08.004
Links
Tools
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment
Journal article published in 2023 by
Wei Ao,
Hong Im Kim,
Domenic Tommarello,
Kelly A. Conrads,
Brian L. Hood,
Tracy Litzi,
Tamara Abulez 
,
Pang-Ning Teng,
Clifton L. Dalgard,
Xijun Zhang,
Matthew D. Wilkerson,
Kathleen M. Darcy,
Christopher M. Tarney,
Neil T. Phippen,
Christopher J. Bakkenist
and other authors.
,
Pang-Ning Teng,
Clifton L. Dalgard,
Xijun Zhang,
Matthew D. Wilkerson,
Kathleen M. Darcy,
Christopher M. Tarney,
Neil T. Phippen,
Christopher J. Bakkenist
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 